p38 MAP kinase-dependent regulation of endothelial cell permeability

被引:96
|
作者
Borbiev, T
Birukova, A
Liu, F
Nurmukhambetova, S
Gerthoffer, WT
Garcia, JGN
Verin, AD
机构
[1] Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD 21224 USA
[2] Univ Nevada, Sch Med, Dept Pharmacol, Reno, NV 89557 USA
关键词
thrombin; p38 mitogen-activated protein kinase; caldesmon; transendothelial electrical resistance;
D O I
10.1152/ajplung.00372.2003
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
We have previously shown that thrombin induces endothelial cell barrier dysfunction via cytoskeleton activation and contraction and have determined the important role of endothelial cell myosin light chain kinase (MLCK) in this process. In the present study we explored p38 MAP kinase as a potentially important enzyme in thrombin-mediated endothelial cell contractile response and permeability. Thrombin induces significant p38 MAP kinase activation in a time-dependent manner with maximal effect at 30 min, which correlates with increased phosphorylation of actin- and myosin-binding protein, caldesmon. Both SB-203580 and dominant negative p38 adenoviral vector significantly attenuated thrombin-induced declines in transendothelial electrical resistance. Consistent with these data SB-203580 decreased actin stress fiber formation produced by thrombin in endothelium. In addition, dominant negative p38 had no effect on thrombin-induced myosin light chain diphosphorylation. Thrombin-induced total and site-specific caldesmon phosphorylation (Ser(789)) as well as dissociation of caldesmon-myosin complex were attenuated by SB-203580 pretreatment. These results suggest the involvement of p38 MAP kinase activities and caldesmon phosphorylation in the MLCK-independent regulation of thrombin-induced endothelial cell permeability.
引用
收藏
页码:L911 / L918
页数:8
相关论文
共 50 条
  • [41] Kinetic mechanism for p38 MAP kinase
    LoGrasso, PV
    Frantz, B
    Rolando, AM
    OKeefe, SJ
    Hermes, JD
    ONeill, EA
    BIOCHEMISTRY, 1997, 36 (34) : 10422 - 10427
  • [42] The development p38 MAP kinase inhibitors
    Hynes, John
    Wu, H.
    Dyckman, A. J.
    Lin, S.
    Wrobleski, S. T.
    Gillooly, K. M.
    McIntyre, K. W.
    Pitt, S.
    Shen, D. R.
    Shuster, D. J.
    Xia, X.
    Zhang, R.
    INFLAMMATION RESEARCH, 2007, 56 : S474 - S474
  • [43] TNF-α and serum induce SKALP/elafin gene expression in human keratinocytes by a p38 MAP kinase-dependent pathway
    R. Pfundt
    M. Wingens
    M. Bergers
    M. Zweers
    M. Frenken
    J. Schalkwijk
    Archives of Dermatological Research, 2000, 292 : 180 - 187
  • [44] An IκBα inhibitor causes leukemia cell death through a p38 MAP kinase-dependent, NF-κB-independent mechanism
    Hu, XT
    Janssen, WE
    Moscinski, LC
    Bryington, M
    Dangsupa, A
    Rezai-Zadeh, N
    Babbin, BA
    Zuckerman, KS
    CANCER RESEARCH, 2001, 61 (16) : 6290 - 6296
  • [45] Inhibitors of unactivated p38 MAP kinase
    Bullington, James
    Argentieri, Dennis
    Averill, Kristin
    Carter, Demetrius
    Cavender, Druie
    Fahmy, Bohumila
    Fan, Xiaodong
    Hall, Daniel
    Heintzelman, Geoffrey
    Jackson, Paul
    Leung, Wai-Ping
    Li, Xun
    Ling, Ping
    Olini, Gilbert
    Razler, Thomas
    Reuman, Michael
    Rupert, Kenneth
    Russell, Ronald
    Siekierka, John
    Wadsworth, Scott
    Wolff, Russell
    Xiang, Bangping
    Zhang, Yue-Mei
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (23) : 6102 - 6106
  • [46] The role of p38 MAP kinase in the regulation of tube formation from endothelial cells in a three-dimensional cell culture system
    Rajan, Suja
    Ye, Janming
    Huang, Faqing
    Guo, Yanlin
    FASEB JOURNAL, 2007, 21 (05): : A14 - A14
  • [47] p38 MAP kinase activity modulates αβ T cell development
    Mulroy, T
    Sen, J
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2001, 31 (10) : 3056 - 3063
  • [48] Regulation of p38 MAP kinase activity by preconditioning stimuli in cardiac myocytes
    Nagarkatti, DS
    Shaafi, RI
    MOLECULAR BIOLOGY OF THE CELL, 1997, 8 : 1426 - 1426
  • [49] The stimulation of purinergic P2Y receptors promotes hepatocyte preconditioning via a SRC and p38 map kinase-dependent mechanism
    Carini, R.
    De Cesaris, M. G.
    Alchera, E.
    Splendore, R.
    Piranda, D.
    Baldanzi, G.
    Albano, E.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S53 - S53
  • [50] p38 MAP kinase regulation of oligodendrocyte differentiation with CREB as a potential target
    Bhat, Narayan R.
    Zhang, Peisheng
    Mohanty, Sangeeta B.
    NEUROCHEMICAL RESEARCH, 2007, 32 (02) : 293 - 302